Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Daniel Wolle is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/20/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/13/2023 | ITOS | Buy Now | ITeos Therapeutics | $6.96 | 316.67% | Daniel Wolle9% | $32 → $29 | Maintains | Overweight | Get Alert |
| 09/13/2023 | IMGN | Buy Now | Immunogen | — | — | Daniel Wolle9% | $9 → $22 | Upgrade | Neutral → Overweight | Get Alert |
| 03/16/2023 | ITOS | Buy Now | ITeos Therapeutics | $6.96 | 359.77% | Daniel Wolle9% | $34 → $32 | Maintains | Overweight | Get Alert |
| 03/07/2023 | CARA | Buy Now | Cara Therapeutics | $4.01 | 299% | Daniel Wolle9% | $228 → $192 | Maintains | Overweight | Get Alert |
| 01/23/2023 | IMGN | Buy Now | Immunogen | — | — | Daniel Wolle9% | $8 → $9 | Maintains | Neutral | Get Alert |
